Related Experiment Videos
[Thrombosis, immunology and drugs]
J L Bosson1, B Ducroux, M Mallaret
1Service de médecine interne et angiologie, CHU de Grenoble.
Journal Des Maladies Vasculaires
|January 1, 1992
Summary
False diagnoses of heparin-induced thrombocytopenia occur. This case highlights quinidine-induced lupus mimicking heparin-induced thrombocytopenia, emphasizing immunological testing for venous thrombosis diagnosis.
Area of Science:
- Immunology
- Hematology
- Pharmacology
Background:
- Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin therapy.
- Accurate diagnosis of HIT is crucial to prevent further thrombotic events.
- Drug-induced lupus can present with thrombotic symptoms, complicating differential diagnosis.
Observation:
- A patient presenting with venous thrombosis initially suspected to have HIT.
- Diagnostic workup revealed the absence of heparin-induced antibodies.
- The patient was diagnosed with quinidine-induced lupus erythematosus.
Findings:
- Quinidine, a medication sometimes used for cardiac arrhythmias, can induce a lupus-like syndrome with thrombocytopenia.
- Immunological investigations, including antinuclear antibody (ANA) and anti-double-stranded DNA (anti-dsDNA) testing, are essential for differentiating drug-induced lupus from HIT.
- This case underscores the potential for quinidine to cause a heparin-induced thrombocytopenia-like presentation.
Implications:
- Clinicians should consider drug-induced lupus, particularly quinidine-induced lupus, in the differential diagnosis of thrombocytopenia in patients with venous thrombosis, even when on heparin.
- Comprehensive immunological workup is vital for accurate diagnosis and appropriate management of such cases.
- This emphasizes the importance of a thorough medication review and targeted serological testing in complex thrombotic events.